Stonepine Capital Management as of Dec. 31, 2016
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 23 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Recro Pharma | 13.8 | $23M | 2.9M | 8.06 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 10.2 | $17M | 24M | 0.71 | |
| Alere | 8.4 | $14M | 360k | 38.97 | |
| SciClone Pharmaceuticals | 8.0 | $14M | 1.2M | 10.80 | |
| Viveve Med | 7.9 | $13M | 2.6M | 5.11 | |
| Noveliontherapeuti.. | 7.7 | $13M | 1.5M | 8.42 | |
| Ophthotech | 6.6 | $11M | 2.3M | 4.83 | |
| Cardiome Pharma | 5.2 | $8.7M | 3.2M | 2.76 | |
| Enanta Pharmaceuticals (ENTA) | 4.6 | $7.8M | 232k | 33.50 | |
| Veracyte (VCYT) | 4.5 | $7.5M | 971k | 7.74 | |
| Vericel (VCEL) | 3.4 | $5.7M | 1.9M | 3.00 | |
| Alimera Sciences | 3.0 | $5.0M | 4.6M | 1.08 | |
| BioDelivery Sciences International | 2.7 | $4.6M | 2.6M | 1.75 | |
| Sucampo Pharmaceuticals | 2.3 | $3.8M | 284k | 13.55 | |
| Cumberland Pharmaceuticals (CPIX) | 2.0 | $3.4M | 620k | 5.50 | |
| Flamel Technologies | 2.0 | $3.4M | 326k | 10.39 | |
| Trinity Biotech | 1.8 | $3.0M | 436k | 6.92 | |
| DURECT Corporation | 1.7 | $2.9M | 2.2M | 1.34 | |
| Mallinckrodt Pub | 1.3 | $2.2M | 44k | 49.83 | |
| Cutera | 1.2 | $2.1M | 120k | 17.35 | |
| Juniper Pharmaceuticals Incorporated | 0.8 | $1.3M | 228k | 5.60 | |
| Cti Biopharma | 0.6 | $1.1M | 2.6M | 0.41 | |
| Aviragen Therapeutics | 0.2 | $380k | 309k | 1.23 |
